Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Interest Expenses (2016 - 2025)

CorMedix (CRMD) has disclosed Interest Expenses for 13 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 18823.96% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, up 7627.78% year-over-year, with the annual reading at $2.8 million for FY2025, 7627.78% up from the prior year.
  • Interest Expenses hit $1.8 million in Q4 2025 for CorMedix, up from $948242.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.8 million in Q4 2025 to a low of $3585.0 in Q2 2022.
  • Historically, Interest Expenses has averaged $160455.3 across 5 years, with a median of $8775.5 in 2022.
  • Biggest five-year swings in Interest Expenses: tumbled 31.01% in 2021 and later surged 18823.96% in 2025.
  • Year by year, Interest Expenses stood at $5378.0 in 2021, then surged by 63.16% to $8775.0 in 2022, then surged by 49.44% to $13113.0 in 2023, then fell by 26.77% to $9602.0 in 2024, then soared by 18823.96% to $1.8 million in 2025.
  • Business Quant data shows Interest Expenses for CRMD at $1.8 million in Q4 2025, $948242.0 in Q3 2025, and $6671.0 in Q2 2025.